DATROWAY® (datopotamab deruxtecan-dlnk) has been approved in the U.S. for the treatment of adult patients with unresectable or metastatic hormone receptor (HR) positive, HER2 negative (IHC 0, IHC 1+ ...

( MENAFN - JCN NewsWire) FDA Accepts LEQEMBI (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the treatment of Early Alzheimer's disease LEQEMBI is the only ...

Some may relieve factors that contribute to dyspnea, such as bronchospasm (bronchodilators), or fluid overload (diuretics). Others can help provide symptom relief directly, including opioids ...

These medications are not generally prescribed long-term and they aren't indicated for asthma, given their potential for causing bronchospasm. In some situations, your healthcare provider may ...

Pivotal Study Demonstrated the Combination More Than Doubled Progression-Free Survival Compared to Investigated SOC THOUSAND OAKS, Calif., Jan. 17, 2025 /PRNewswire/ ...

The widespread fires that are devastating the Los Angeles area is one of the most destructive in the city's history, but the impact of it extends far beyond structural damage. Sneaky-small particles ...

Chronic heart failure (CHF) is associated with frequent hospitalizations and high mortality. It affects more than 5 million individuals in the USA, and another 660,000 new cases are diagnosed each ...

Increasing Prevalence of Asthma and COPD: The rising incidence of asthma and chronic obstructive pulmonary disease (COPD) ...

The announcement that inhaled insulin will soon be available in India has understandably generated a lot of excitement and ...